Welcome to our latest blog post! Today, we're exploring the fascinating world of central retinal artery occlusion (CRAO) – a condition that affects millions of people around the globe. As medical professionals, it's essential to understand this eye condition thoroughly so you can diagnose and treat it effectively. In this article, we'll discuss the different types of CRAO, how it's diagnosed, its causes, symptoms and treatment options available. So sit back and get ready for an informative read on everything you need to know about central retinal artery occlusion!
There are two types of central retinal artery occlusion (CRAO) – non-arteritic and arteritic. Non-arteritic CRAO is the most common type, accounting for around 90% of cases. It occurs when a blood clot or other blockage forms in the central retinal artery, which supplies oxygen and nutrients to the retina.
Arteritic CRAO, on the other hand, is much less common but more severe. It's caused by inflammation and narrowing of the arteries due to an autoimmune disease called giant cell arteritis (GCA). This condition affects people over 50 years old and requires immediate treatment with high-dose corticosteroids to prevent permanent vision loss.
Central Retinal Artery Occlusion (CRAO) is a medical emergency that requires urgent diagnosis and treatment. The diagnosis process usually begins with a thorough eye examination, including an assessment of visual acuity, intraocular pressure, pupil reactions, and the appearance of the retina.
Ophthalmoscopy is another diagnostic tool that can help identify CRAO. During this procedure, an ophthalmologist or optometrist will examine the inside of your eye using a specialized instrument called an ophthalmoscope.
In addition to these methods, imaging tests such as fluorescein angiography and optical coherence tomography (OCT) may also be used to diagnose CRAO. These tests can provide detailed images of the blood vessels in your eyes and detect any blockages or abnormalities.
One of the most common treatments for CRAO is ocular massage, which involves applying gentle pressure on the closed eyelids to help dislodge any blockages in the central retinal artery. Another treatment option is administering drugs that dilate blood vessels and increase blood flow to the retina.
Central retinal artery occlusion is a serious eye condition that can lead to permanent vision loss if not diagnosed and treated promptly. Medical professionals should be aware of the different types, causes, symptoms and diagnostic methods for CRAO in order to provide effective treatment and prevent further complications.
Early diagnosis with fundus examination or OCT angiography followed by immediate management including ocular massage, anterior chamber paracentesis or hyperbaric oxygen therapy can help improve visual outcomes in patients with central retinal artery occlusion.
It's also important for medical professionals to educate their patients on the risk factors associated with this condition such as hypertension, diabetes mellitus and high cholesterol levels. Encouraging regular eye exams can help detect any changes early on before they progress into more serious conditions like CRAO.
Understanding the nuances of central retinal artery occlusion is key in providing optimal care for patients experiencing this condition.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation